The Parenteral Drug Association (PDA) is a nonprofit organization established in 1946, dedicated to advancing science, technology, and regulation in pharmaceutical and biopharmaceutical manufacturing, with a focus on injectable products. Headquartered in Bethesda, Maryland, PDA has over 10,500 members globally, including scientists, manufacturers, suppliers, and regulatory officials. The organization promotes collaboration and knowledge exchange through its various initiatives and resources. PDA offers a range of educational and technical resources, including conferences, meetings, and courses that address key industry challenges such as sterilization and aseptic processing. It publishes the *PDA Journal of Pharmaceutical Science and Technology* and the *PDA Letter*, providing peer-reviewed research and industry news. Additionally, the PDA Training and Research Institute (PDA-TRI) offers hands-on training and practical guidance to ensure compliance with regulatory standards. Through these efforts, PDA supports public health by enhancing product quality and manufacturing practices in the pharmaceutical sector.